Quick Answer
Seres Therapeutics, Inc. reported Total Revenue of $789.0 thousand for the year ending 2025.
- This data is from Seres Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2015 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $0.00 | Q3 2014: $0.00 | Q2 2015: $0.00 | Q3 2015: $0.00 | Q1 2016: $2.71 million | Q2 2016: $3.00 million | Q3 2016: $13.02 million | Q1 2017: $3.02 million | Q2 2017: $3.01 million | Q2 2017: $3.01 million | Q3 2017: $23.02 million | Q1 2018: $3.97 million | Q1 2018: $3.77 million | Q2 2018: $4.27 million | Q2 2018: $4.61 million | Q3 2018: $9.06 million | Q3 2018: $8.68 million | Q1 2019: $7.32 million | Q1 2019: $6.62 million | Q2 2019: $12.53 million | Q2 2019: $10.45 million | Q3 2019: $7.03 million | Q3 2019: $4.84 million | Q1 2020: $8.19 million | Q1 2020: $5.46 million | Q2 2020: $5.19 million | Q2 2020: $6.05 million | Q3 2020: $1.42 million | Q3 2020: $80.0 thousand | Q1 2021: $5.72 million | Q1 2021: $4.65 million | Q2 2021: $5.26 million | Q2 2021: $5.26 million | Q3 2021: $126.73 million | Q3 2021: $126.73 million | Q1 2022: $1.49 million | Q1 2022: $1.49 million | Q2 2022: $1.22 million | Q2 2022: $1.22 million | Q3 2022: $3.44 million | Q3 2022: $3.44 million | Q1 2023: -$522.0 thousand | Q2 2023: $126.47 million | Q3 2023: $310.0 thousand | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00 | Q3 2025: $351.0 thousand.
- Historical annual values: Fiscal year 2025: $789.0 thousand | Fiscal year 2024: $0.00 | Fiscal year 2023: $0.00 | Fiscal year 2022: $7.13 million | Fiscal year 2022: $7.13 million | Fiscal year 2021: $143.86 million | Fiscal year 2021: $144.93 million | Fiscal year 2020: $33.22 million | Fiscal year 2020: $11.90 million | Fiscal year 2019: $27.19 million | Fiscal year 2019: $34.51 million | Fiscal year 2018: $26.92 million | Fiscal year 2018: $28.27 million | Fiscal year 2017: $32.10 million | Fiscal year 2017: $32.10 million | Fiscal year 2016: $21.77 million | Fiscal year 2016: $21.77 million | Fiscal year 2015: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: